<DOC>
	<DOCNO>NCT00995033</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety NicVAX co-administered varenicline aid smoking cessation one-year period smoker want quit smoking .</brief_summary>
	<brief_title>Efficacy Safety NicVAX® Co-administered With Varenicline ( Champix® )</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Smokes least 10 cigarette per day Good general health Negative pregnancy test prior study entry Prior exposure NicVAX nicotine vaccine Known allergic reaction alum component vaccine Use systemic steroid , immunosuppressive agent medication might interfere immune response Cancer cancer treatment last 5 year HIV infection History drug alcohol abuse dependence within 12 month Significant cardiovascular , hepatic , renal , psychiatric and/or respiratory disease Previous intolerance varenicline Inability fulfill visit approximately 54 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>Smoking lapse behavior</keyword>
	<keyword>Smoking Relapse behavior</keyword>
	<keyword>Varenicline</keyword>
	<keyword>Nicotine conjugate vaccine</keyword>
	<keyword>Medication effect smoke lapse behavior</keyword>
</DOC>